Sunesis Pharmaceuticals, Inc (SNSS)

Etorro trading 970x250

About Sunesis Pharmaceuticals, Inc

As of February 24, 2021, Sunesis Pharmaceuticals, Inc. was acquired by Viracta Therapeutics, Inc., in a reverse merger transaction. Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of targeted inhibitors for the treatment of hematologic and solid cancers. Its lead product candidate is vecabrutinib, a non-covalent inhibitor of Bruton’s tyrosine kinase (BTK), which is in Phase 1b/2 clinical trial for the treatment of chronic lymphocytic leukemia, mantle cell lymphoma, and other B-cell malignancies. The company is also developing SNS-510, which is in preclinical pharmacology studies for the treatment of solid tumor and hematologic malignancies; various other partnered programs, such as TAK-580, a pan-Raf inhibitor program that is in Phase 1 clinical trial for the treatment of pediatric low-grade glioma; and vosaroxin, an anti-cancer quinolone derivative that intercalates DNA and inhibits topoisomerase II. It has a collaboration agreement with Biogen Idec MA, Inc. to discover, develop, and commercialize small molecule BTK inhibitors; and license agreement with Takeda Pharmaceutical Company Limited to develop and commercialize preclinical inhibitors of PDK1. Sunesis Pharmaceuticals, Inc. was founded in 1998 and is headquartered in South San Francisco, California. Address: 395 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Sunesis Pharmaceuticals, Inc News and around…

Latest news about Sunesis Pharmaceuticals, Inc (SNSS) common stock and company :

80 Biggest Movers From Yesterday
25 Feb, 2021 FinancialContent

Gainers GameStop Corp. (NYSE: GME) shares surged 103.9% to close at $91.71 on Wednesday after the stock spiked on heavy volume. ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
24 Feb, 2021 FinancialContent

Gainers Dynatronics (NASDAQ:DYNT) stock rose 63.28% to $2.09 during Wednesday's after-market session. Dynatronics's trading ...

Why Sunesis, Poseida, Salarius And PRA Health Are Rallying
24 Feb, 2021 FinancialContent

A slew of healthcare stocks is moving on Wednesday in reaction to company-specific catalysts. Sunesis Rises On Hopes of Completion of ...

61 Stocks Moving In Wednesday's Mid-Day Session
24 Feb, 2021 FinancialContent

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares jumped 193.3% to $11.00. Novo Integrated Sciences, on Tuesday, ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
24 Feb, 2021 FinancialContent

Gainers Novo Integrated Sciences, Inc. - Common Stock (NASDAQ:NVOS) shares moved upwards by 183.54% to $11.31 during ...

Mid-Day Market Update: US Stocks Turn Higher; Systemax Shares Fall Following Q4 Earnings
24 Feb, 2021 FinancialContent

Midway through trading Wednesday, the Dow traded up 0.90% to 31,820.21 while the NASDAQ rose 0.54% to 13,537.51. The S&P also rose, ...

Mid-Morning Market Update: Markets Open Lower; Lowe's Beats Q4 Estimates
24 Feb, 2021 FinancialContent

Following the market opening Wednesday, the Dow traded down 0.28% to 31,450.55 while the NASDAQ fell 1.2% to 13,303.70. The S&P also ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
24 Feb, 2021 FinancialContent

Gainers Novo Integrated Sciences, Inc. - Common Stock (NASDAQ:NVOS) stock moved upwards by 371.58% to $18.81 during ...

88 Biggest Movers From Yesterday
24 Feb, 2021 FinancialContent

Gainers Solid Biosciences Inc. (NASDAQ: SLDB) shares surged 41.8% to close at $9.74 on above-average session volume. TimkenSteel ...

SNSS Stock: Why Sunesis Pharmaceuticals Is Soaring Today
23 Feb, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips An analyst upgrade is the near-term catalyst, but for Sunesis Pharmaceuticals, it's really about patents in oncology and an impending merger with Viracta. The post SNSS Stock: Why Sunesis Pharmaceuticals Is Soaring Today appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next Potential Winner It doesn’t matter if you have $500 in savings or $5 million. Do this now. #1 Play to Profit from Biden's Presidency

Mid-Afternoon Market Update: Dow Falls 60 Points; Churchill Capital IV Shares Plunge
23 Feb, 2021 FinancialContent

Toward the end of trading Tuesday, the Dow traded down 0.19% to 31,461.29 while the NASDAQ fell 1.43% to 13,340.01. The S&P also ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
23 Feb, 2021 FinancialContent

Gainers Sunesis Pharmaceuticals (NASDAQ:SNSS) stock rose 25.84% to $4.48 during Tuesday's regular session. Trading ...

Mid-Day Market Update: Nasdaq Drops 250 Points; Frank's International Shares Jump Following Q4 Earnings
23 Feb, 2021 FinancialContent

Midway through trading Tuesday, the Dow traded down 0.48% to 31,369.07 while the NASDAQ fell 1.96% to 13,267.36. The S&P also fell, ...

65 Stocks Moving In Tuesday's Mid-Day Session
23 Feb, 2021 FinancialContent

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares jumped 64.1% to $3.8899. Vascular Biogenics Ltd. (NASDAQ: VBLT) gained 37.7% to ...

Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2021
23 Feb, 2021 FinancialContent

Upgrades Exane BNP Paribas upgraded the previous rating for NatWest Group PLC (NYSE:NWG) from Underperform to Neutral. ...

Mid-Morning Market Update: Markets Open Lower; Home Depot Tops Q4 Views
23 Feb, 2021 FinancialContent

Following the market opening Tuesday, the Dow traded down 0.29% to 31,431.18 while the NASDAQ fell 1.21% to 13,368.87. The S&P also ...

Best Penny Stocks To Buy Now As Markets Turn Lower? 3 To Watch
23 Feb, 2021 FinancialContent
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
23 Feb, 2021 FinancialContent

Gainers Vascular Biogenics (NASDAQ:VBLT) shares moved upwards by 28.25% to $2.86 during Tuesday's pre-market ...

48 Stocks Moving in Tuesday's Pre-Market Session
23 Feb, 2021 FinancialContent

Gainers Vascular Biogenics Ltd. (NASDAQ: VBLT) rose 67.3% to $3.73 in pre-market trading. Vascular Biogenics, on Monday, announced ...

Sunesis Pharma Climbs After Viracta Poised To Nab US Patent For Nanatinostat/Valganciclovir Regime
16 Feb, 2021 FinancialContent

Sunesis Pharmaceuticals Inc(NASDAQ:SNSS) merger partner,Viracta Therapeutics Incannounces that the U.S. ...

Stocks That Hit 52-Week Highs On Wednesday
10 Feb, 2021 FinancialContent

This morning 533 companies reached new 52-week highs. Intriguing Points: The largest company on a market ...

Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch In January
18 Jan, 2021 FinancialContent
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SNSS, LOAC, FBSS, and CPAH Mergers
07 Jan, 2021 FinancialContent
Stocks That Hit 52-Week Highs On Thursday
07 Jan, 2021 FinancialContent

Thursday's morning session saw 641 companies set new 52-week highs. Noteworthy Highlights: Tesla ...

Stocks That Hit 52-Week Highs On Monday
04 Jan, 2021 FinancialContent

During Monday's morning session, 286 stocks hit new 52-week highs. Areas of Interest: The company with the ...

Great trade setups to trade next week
02 Jan, 2021 FinancialContent
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of UROV, SNSS, TCF, and PS Mergers
30 Dec, 2020 FinancialContent
SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS
29 Dec, 2020 FinancialContent

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Sunesis Pharmaceuticals, Inc. (NasdaqGS: SNSS) with Viracta Therapeutics, Inc. pursuant to which Sunesis shareholders will end up owning just 14% of the combined company, subject to adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of INFO, SNSS, INSU, and FBSS Mergers
17 Dec, 2020 FinancialContent
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm – SNSS, WORK, WDR, ANH
12 Dec, 2020 FinancialContent

Sunesis Pharmaceuticals, Inc (SNSS) is a NASDAQ Common Stock listed in , ,

970x250